Key facts
- Synonym (Consulting Services (B2B))’s last known valuation is $83.5M (Nov 2025).
- It has raised $24.7M; the latest was Early Stage VC ($18.4M) in Nov 2025.
- Notable investors include Andreessen Horowitz, FJ Labs, Global Founders Capital, In-Q-Tel, Clocktower Ventures — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Synonym (Consulting Services (B2B))
- ·The full record, as it builds
Funding rounds
No funding rounds for Synonym (Consulting Services (B2B)) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Synonym (Consulting Services (B2B))
Developer of a biomanufacturing acceleration platform intended for accelerating production and market adoption of materials and ingredients made with biology. The company's platform offers bioproduct-related data services and facilitates production through its network of capacity partners, enabling industries to meet the growing population's increasing bioproduction needs.
- Sector
- Business Products and Services (B2B)
- HQ
- New York, NY, United States
- Founded
- 2021
- Employees
- 46
- Website
- synonym.bio/
- Ownership
- Privately Held (backing)
Synonym (Consulting Services (B2B)) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Synonym (Consulting Services (B2B)) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Synonym (Consulting Services (B2B)) in its N-PORT filings yet. We sweep new filings monthly.